Alkermes Plc Earnings
The next earnings date for Alkermes Plc is October 23, 2025.
They are scheduled to announce earnings before the market opens that day.
Analyst Estimates of Alkermes Plc Earnings
| Report Date | Estimated Earnings Per Share |
|---|
| 10/23/2025 | $0.39 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Alkermes Plc Earnings: Historical
| Report Date | Before/After Market | Earnings Per Share | Surprise % |
|---|
| 07/22/2025 | Before Market | --- | --- |
| 04/29/2025 | Before Market | $0.29 | 18.87% |
| 02/12/2025 | --- | $1.05 | 37.61% |
| 10/24/2024 | Before Market | $0.72 | -2.70% |
| 07/24/2024 | Before Market | $0.70 | 0.00% |
| 05/01/2024 | Before Market | $0.43 | -25.86% |
| 02/15/2024 | Before Market | $0.22 | -56.86% |
| 10/25/2023 | Before Market | $0.64 | 45.45% |
| 07/26/2023 | Before Market | $0.55 | 19.57% |
| 04/26/2023 | Before Market | $0.01 | 200.00% |
| 02/16/2023 | Before Market | $0.14 | 180.00% |
| 11/02/2022 | Before Market | $0.02 | -33.33% |
| 07/27/2022 | Before Market | $0.06 | 500.00% |
| 04/27/2022 | Before Market | $0.12 | 1,100.00% |
| 02/16/2022 | Before Market | $0.23 | 187.50% |
| 10/27/2021 | Before Market | $0.14 | 133.33% |
| 07/28/2021 | Before Market | $0.30 | 150.00% |
| 04/28/2021 | Before Market | $0.11 | 650.00% |
| 02/11/2021 | Before Market | $0.10 | 42.86% |
| 10/29/2020 | Before Market | $0.26 | 12,900.00% |
| 07/29/2020 | Before Market | $0.06 | 700.00% |
| 04/29/2020 | Before Market | $0.01 | 116.67% |
| 02/13/2020 | Before Market | $0.83 | 27.69% |
| 10/23/2019 | Before Market | $-0.04 | 80.95% |
| 07/25/2019 | Before Market | $0.09 | 175.00% |
| 04/25/2019 | Before Market | $-0.17 | 19.05% |
| 02/14/2019 | Before Market | $0.34 | 950.00% |
| 10/23/2018 | Before Market | $0.07 | 200.00% |
| 07/26/2018 | Before Market | $0.29 | 107.14% |
| 04/26/2018 | Before Market | $-0.09 | -28.57% |
| 02/14/2018 | Before Market | $0.31 | 34.78% |
| 10/26/2017 | Before Market | $0.03 | 400.00% |
| 07/27/2017 | Before Market | $0.01 | 200.00% |
| 04/27/2017 | Before Market | $-0.18 | -100.00% |
| 02/15/2017 | Before Market | $0.15 | 275.00% |
| 11/02/2016 | Before Market | $-0.09 | -50.00% |
| 07/28/2016 | Before Market | $-0.01 | 90.00% |
| 04/28/2016 | Before Market | $-0.16 | 20.00% |
| 02/25/2016 | Before Market | $-0.15 | 16.67% |
| 10/29/2015 | Before Market | $-0.18 | 14.29% |
| 07/30/2015 | Before Market | $-0.09 | 10.00% |
| 04/30/2015 | Before Market | $0.06 | 300.00% |
| 02/24/2015 | Before Market | $0.11 | 175.00% |
| 10/29/2014 | Before Market | $0.03 | 50.00% |
| 07/31/2014 | --- | $0.11 | -21.43% |
| 04/30/2014 | --- | $0.11 | 10.00% |
| 02/27/2014 | --- | $0.27 | 35.00% |
| 10/31/2013 | --- | $0.22 | -4.35% |
| 07/25/2013 | --- | $0.30 | 36.36% |
| 05/23/2013 | --- | $0.40 | 135.29% |
| 01/31/2013 | --- | $0.34 | 47.83% |
| 11/01/2012 | --- | $0.17 | 70.00% |
| 07/26/2012 | --- | $0.39 | 143.75% |
| 05/17/2012 | --- | $-0.13 | 13.33% |
| 02/02/2012 | --- | $-0.11 | 47.62% |
| 11/03/2011 | --- | $-0.22 | -83.33% |
| 08/01/2011 | --- | $-0.14 | -27.27% |
| 05/18/2011 | --- | $-0.14 | 0.00% |
| 02/03/2011 | --- | $-0.12 | 20.00% |
| 11/04/2010 | --- | $-0.08 | 46.67% |
| 08/05/2010 | --- | $-0.14 | 0.00% |
| 05/13/2010 | --- | $-0.15 | 0.00% |
| 02/04/2010 | --- | $-0.07 | 56.25% |
| 11/05/2009 | --- | $-0.09 | 0.00% |
| 08/06/2009 | --- | $-0.11 | -37.50% |
| 05/21/2009 | --- | $-0.14 | -16.67% |
| 02/05/2009 | --- | $1.17 | -3.31% |
| 11/06/2008 | --- | $0.02 | 200.00% |
| 08/07/2008 | --- | $0.31 | 40.91% |
| 05/22/2008 | --- | $-0.19 | -1,037.00% |
| 02/07/2008 | --- | $-0.02 | -100.00% |
| 11/01/2007 | --- | $0.07 | 75.00% |
| 08/02/2007 | --- | $0.08 | 100.00% |
| 05/29/2007 | --- | $0.03 | 200.00% |
| 02/07/2007 | --- | $0.03 | --- |
| 11/02/2006 | --- | $0.04 | 200.00% |
| 08/08/2006 | --- | $-0.01 | --- |
| 05/18/2006 | --- | $0.04 | 200.00% |
| 02/07/2006 | --- | $0.02 | 125.00% |
| 11/03/2005 | --- | $0.12 | 209.09% |
| 08/04/2005 | --- | $-0.15 | 16.67% |
| 05/19/2005 | --- | $-0.16 | 5.88% |
| 02/03/2005 | --- | $-0.10 | 28.57% |
| 11/04/2004 | --- | $-0.16 | 23.81% |
| 08/05/2004 | --- | $-0.29 | -45.00% |
| 05/13/2004 | --- | $-0.28 | -64.71% |
| 02/11/2004 | --- | $-0.23 | 17.86% |
| 11/05/2003 | --- | $-0.31 | -34.78% |
| 08/07/2003 | --- | $-0.44 | -51.72% |
| 05/29/2003 | --- | $-0.30 | 6.25% |
| 02/12/2003 | --- | $-0.20 | 35.48% |
| 11/07/2002 | --- | $-0.41 | -32.26% |
| 08/14/2002 | --- | $-0.33 | -3.13% |
| 06/27/2002 | --- | $-0.35 | -12.90% |
| 02/14/2002 | --- | $-0.28 | -3.70% |
| 11/08/2001 | --- | $-0.20 | 20.00% |
| 08/14/2001 | --- | $-0.13 | 45.83% |
| 05/23/2001 | --- | $-0.22 | 31.25% |
| 02/13/2001 | --- | $-0.17 | 51.43% |
| 11/13/2000 | --- | $-0.19 | 44.12% |
| 08/14/2000 | --- | $0.13 | 218.18% |
| 06/28/2000 | --- | $-0.59 | -84.38% |
| 02/14/2000 | --- | $-0.38 | -35.71% |
| 11/15/1999 | --- | $-0.33 | -10.00% |
| 08/16/1999 | --- | $-0.20 | 25.93% |
| 06/24/1999 | --- | $-0.30 | -11.11% |
| 02/12/1999 | --- | $-0.09 | 40.00% |
| 10/07/1998 | --- | $-0.09 | 10.00% |
| 06/30/1998 | --- | $-0.16 | --- |
| 06/05/1998 | --- | $-0.04 | 66.67% |
| 02/11/1998 | --- | $-0.07 | 30.00% |
| 11/11/1997 | Before Market | $-0.02 | 81.82% |
| 08/08/1997 | Before Market | $-0.09 | 25.00% |
| 05/23/1997 | --- | $-0.12 | 20.00% |
| 01/17/1997 | --- | $-0.11 | 21.43% |
| 11/08/1996 | --- | $-0.13 | 7.14% |
| 08/12/1996 | --- | $-0.14 | 6.67% |
| 06/21/1996 | --- | $-0.18 | -28.57% |
| 02/14/1996 | --- | $-0.08 | 33.33% |
More About Alkermes Plc
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
“Alkermes Plc Earnings” Can Refer to the Alkermes Plc Earnings Date
Some people say “Alkermes Plc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Alkermes Plc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Alkermes Plc Stock on the Earnings Date
If you own Alkermes Plc stock (ALKS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Alkermes Plc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Alkermes Plc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Alkermes Plc Earnings
You can contact us any time if you would like to ask questions about Alkermes Plc earnings or anything else related to the stock market.